慢性乙型肝炎肝衰竭患者血清甲胎蛋白和胸腺素β4水平变化

doi:10.3969/j.issn.1672-5069.2017.03.026

Abstract

Li Hongzhi, Guo Xinxin. Serum alpha-fetoprotein and thymosin β4 levels in prognosis of patients with hepatitis B liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 354-355.

[1] Sarin SK,Kumar A,Almeida JA,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int,2014,3(4):269-282.
[2] Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Association for the study of liver diseases,American College of Gastroenterology,and the American Gastroenterological Association. Hepatology,2012,143(6):503-505.
[3] 方明霞,齐蕾. 血浆置换治疗慢性乙型肝炎肝衰竭临床疗效观察. 实用肝脏病杂志,2015,18(3):292-293.
[4] 王婧涵,李嘉,赵新颜. 慢性乙型肝炎和乙肝肝硬化及原发性肝癌血清肿瘤标志物的检测意义. 临床和实验医学杂志,2013,12(21):1702-1705.
[5] 刘德胜,肖诗亮,王博,等. 缺氧环境中胸腺素β4基因转染骨髓间充质干细胞凋亡率及Bax和Bcl-2的表达. 中国组织工程研究,2014,18(41):6573-6577.
[6] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案. 中华内科杂志,2001,40(1):62-68.
[7] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南.实用肝脏病杂志,2013,16(3):210-216.
[8] 胡珊珊,孙克伟,张茜茜,等. 慢性乙型肝炎病毒感染不同免疫状态患者树突状细胞体外刺激后介导的T淋巴细胞功能影响的研究. 中国中西医结合杂志,2014,34(4):418-422.
[9] 侯晓玫,杜琰,郭世昌,等. microRNA在慢性乙型肝炎、肝硬化、肝细胞癌进化过程中的作用. 第二军医大学学报,2015,36(9):997-1002.
[10] Salkic NN,Jovanovic P,Hauser G,et al.FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B:a meta-analysis. Am J Gastroenterol,2014,109(6):796-809.
[11] 王伟静,项晓刚,赵钢德,等. 血清微小核糖核酸-122在慢性乙型肝炎肝功能衰竭患者中的表达及其与疾病严重程度的关系. 中华传染病杂志,2014,32(5):269-273.
[12] 刘莹,韩涛,朱争艳,等. 血清胸腺素β4动态变化在肝衰竭患者预后判断中的价值. 中华肝脏病杂志,2011,19(2):138-139.
[13] Kim J,Wang S,Hyun J,et al.Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver. Plos One,2015,10(3):e0122758-e0122761.
[14] Knop J,App C,Huff T,et al.Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking. Expert Opin Biol Ther,2015,15(S1):1-8.
[15] 付晓君,刘弋. 胸腺素beta-4在肝母细胞瘤肝组织中的表达及其临床病理意义. 安徽医科大学学报,2014,12(9):1305-1309.
[16] 张蕾,陈源文,徐雷鸣. 胸腺素β_4-脯氨酸寡肽酶-AcSDKP轴在肝内生物学功能的研究. 胃肠病学和肝病学杂志,2011,20(4):299-301.
[17] Theunissen W,Fanni D,Nemolato S,et al.Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma. Eur J Histochem,2014,58(1):2242-2242.
[18] Seo SI,Kim HS,Kim WJ,et al.Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol,2015,21(13):3928-3935.
[19] 王丰园,章林华,赖卫强,等. 血清纤维化指标联合AFP和铁蛋白检测在肝硬化患者Child-Pugh分级中的价值. 检验医学,2014, 29(12):1222-1225.
[20] Yamada R,Hiramatsu N,Oze T,et al.Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection. J Gastroenterol,2015,50(7):1-10.
[21] 赵世印,李芳,谭华炳. 苦参素胶囊对乙型肝炎后肝硬化患者高甲胎蛋白影响研究. 辽宁中医药大学学报,2014,4(1):179-181.
[22] Yamagiwa S,Tamura Y,Takamura M,et al.Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure. Hepatol Res,2014,44(14):368-375.

Serum alpha-fetoprotein and thymosin β4 levels in prognosis of patients with hepatitis B liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[8]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[9]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[10]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[11]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[12]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[13]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.